TUM SIeber Lab - Phosphoaspartate probe for P. aeruginosa interkingdom signaling study

TUM SIeber Lab - Phosphoaspartate probe for P. aeruginosa interkingdom signaling study
A tailored phosphoaspartate probe unravels CprR as a response regulator in Pseudomonas aeruginosa interkingdom signaling
Data License: CC BY 4.0 | ProteomeXchange: PXD022470
  • Organism: Pseudomonas aeruginosa PAO1
  • Instrument: Q Exactive Plus
  • SpikeIn: Yes
  • Keywords: Activity-based protein profiling, isotopically labeled tags, phosphorylation, response regulator, parallel reaction monitoring, adaptive resistance, antimicrobial peptide, P. aeruginosa
  • Lab head: Stephan Sieber Submitter: Patrick Allihn
Abstract
Pseudomonas aeruginosa is a difficult-to-treat Gram-negative bacterial pathogen causing life-threatening infections. Adaptive resistance (AR) to cationic peptide antibiotics such as polymyxin B impairs the therapeutic success. This self-protection is mediated by two component systems consisting of a membrane-bound histidine kinase and an intracellular response regulator (RR). As phosphorylation of the key RR aspartate residue is transient during signaling and hydrolytically unstable, the study of these systems is challenging. Therefore, we applied a tailored reverse polarity chemical proteomic strategy to capture this transient modification and read-out RR phosphorylation in complex proteomes using a nucleophilic probe. Analysis of Bacillus subtilis and P. aeruginosa proteomes revealed the detection of multiple phosphoaspartate sites, which closely resembled the conserved RR sequence motif. With this validated strategy we dissected the signaling of dynorphin A, a human peptide stress hormone, which is sensed by P. aeruginosa to prepare AR. Intriguingly, our methodology combined with parallel reaction monitoring identified CprR as an unprecedented RR in dynorphin A interkingdom signaling.
Experiment Description
Using our probe (HA-yne) together with our isotopically labeled desthiobiotin azide (isoDTB) tags, we applied a tailored reverse polarity activity-based protein profiling (RP-ABPP) strategy to examine aspartate phosphorylated sites in P. aeruginosa upon dynorphin A treatment. PRM method development: Based on the results of the quantitative data dependent acquisition (DDA) isoDTB experiments, the most interesting HA-yne modified peptides with the highest light to heavy MS1 ratios (L/H) were chosen for PRM measurements. The corresponding peptides from the response regulators CprR and ParR were selected for fragmentation, showing the highest or a so far uncharacterized MS1 ratio (light to heavy), respectively. Additionally, two peptides (from response regulators GacA and PhoP) with an MS1 ratio of roughly one, were chosen as controls. Precursors for fragmentation were selected based on their respective most intense charge state from the DDA measurements analyzed by MS1 Filtering using Skyline (version 20.2.1.286). Experimental spectral libraries were built within Skyline using DDA and PRM isoDTB data processed with MaxQuant. For retention time comparison, PROCAL retention time peptides (JPT Peptide Technologies) were used, consisting of 40 non-naturally occurring peptides. PROCAL peptides were spiked into the samples (final quantity: 100 fmol/peptide). For 34 PROCAL peptides only MS1 chromatogram information was acquired in PRM mode, while five PROCAL peptides were also selected for fragmentation.
Sample Description
isoDTB-ABPP Experiments in dynorphin A treated P. aeruginosa: P. aeruginosa overnight cultures were inoculated in fresh minimal medium and grown to OD600 = 0.8-1.0. Cells were harvested, washed with PBS, resuspended to OD600 = 1 in PBS and incubated at 37 °C. Dynorphin A (1-13) (final concentration: 10 µM) or DMSO were added and incubated for 1 min at 37 °C. The cells were harvested, washed with PBS and resuspended to OD600 = 40 in 1 mL of HA-yne buffer (20 mM HEPES, pH 4.0, 125 mM HA-yne, 1% (w/v) LDAO). Cells were lyzed by sonication and the reaction proceeded for 1 h at 37 °C. Fractions were separated by centrifugation and the insoluble fraction was washed twice with PBS and stored at -20 °C until subjection to click chemistry. The soluble fraction was precipitated acetone (-80 °C) and incubated overnight at -20 °C. The precipitate was centrifuged and washed twice with MeOH (-80 °C. Soluble and insoluble fractions were resuspended in 0.8% SDS in PBS and protein concentration of both fractions was determined by BCA assay and adjusted to 0.5 mg/mL with 0.8% SDS in PBS. Dynorphin A treated samples were clicked to the light isoDTB tag and DMSO treated samples were clicked to the heavy isoDTB tag by addition of TBTA ligand, the respective isoDTB tag, TCEP and CuSO4. The click reaction was incubated for 1 h at room temperature and quenched by combination of light and heavy isoDTB-tagged samples into acetone (-80 °C). MS Sample Preparation for RP-ABPP and isoDTB-ABPP Experiments: Precipitates were centrifuged and washed twice with MeOH (-80 °C). Pellets were dissolved in 8 M urea in 0.1 M triethylammonium bicarbonate and after reduction of disulfides by addition of dithiothreitol (DTT) and incubation at 37 °C for 45 min, free thiols were alkylated by adding iodoacetamide (IAA) and incubation in the dark at 25 °C for 30 min. Remaining IAA was quenched by addition of DTT and incubation at 25 °C for 30 min. 0.1 M TEAB was added to obtain a urea concentration of 2 M for trypsin digestion. 20 µL of 0.5 µg/µL trypsin were added and samples were incubated at 37 °C overnight. This solution was added to washed streptavidin agarose beads in 0.2% nonyl phenoxypolyethoxylethanol (NP-40 alternative). The samples were incubated by rotation at room temperature for 1 h. To remove unbound peptides, the beads were centrifuged and the supernatant was removed. The beads were resuspended in 0.1% NP 40 alternative in PBS and transferred to a centrifuge column. The beads were washed with 0.1% NP 40 alternative, PBS and ddH2O. The peptides were eluted by addition of elution buffer (0.1% formic acid (FA) in 1:1 ACN/H2O) and two more elution steps, followed by centrifugation. The solvent was removed using a vacuum centrifuge and samples were dissolved by addition of 30 µL 1% FA in H2O and sonication for 3 min. The samples were filtered and transferred into MS vials for LC MS/MS analysis. PRM LC-MS/MS Analysis: For PRM measurements, PROCAL retention time peptides were spiked into the samples (v/v 1:6) directly before measurement. 6 µL of sample were injected in order to obtain similar intensities as in previous DDA measurements and 100 fmol/peptide of the PROCAL retention time peptides. Samples (injection volume: 5 µL) were analyzed with a nano HPLC system coupled to a Q Exactive Plus mass spectrometer. Samples were loaded on a C18 trap column, washed with 0.1% TFA and separated on a C18 column with a flow of 300 nL/min using buffer A (0.1% FA in H2O) and buffer B (0.1% FA in ACN): 5% B for 7 min, 5 40% B in 105 min, 40 60% B in 10 min, 60 90% B in 10 min, 90% B for 10 min, 90 5% B in 0.1 min, 5% B for 9.9 min. For PRM measurements, the mass spectrometer was operated in PRM mode. Full MS (MS1) scans were acquired at a resolution of 70,000, a scan range of m/z = 300 1500 Th, an automatic gain control (AGC) target of 3e6, and a maximum injection time of 80 ms. Targeted MS2 scans were acquired at a resolution of 17,500, an AGC target of 1e5, and a maximum injection time of 100 ms. The number of targeted precursors was adjusted to maintain a maximum cycle time of 2 s for at least 8 points across the peak in a non-scheduled PRM measurement. In total, 4 different HA yne-modified peptides from proteins CprR, ParR, GacA and PhoP (light/heavy isoDTB version) and 5 PROCAL peptides were targeted (in comparison for DDA measurements: Top10). Quadrupole isolation of the precursor was set to a window of 1.6 Th. Fragment ions were generated using higher-energy dissociation (HCD) with a normalized collision energy (NCE) of 27% and detected in the orbitrap. PRM Data Analysis: PRM data analysis was performed using the Skyline-daily (64 bit) software (version 20.2.1.286). For all target peptides, the 6 most intense fragment ions (top6) were automatically picked by Skyline using the generated experimental spectral library. Raw PRM data were also processed by MaxQuant in order to visualize in Skyline the exact time point of successful peptide identification for any given MS2 spectrum. Peak picking, peak integration and transition interferences were reviewed and integration boundaries were adjusted manually in Skyline, if necessary. Mass accuracy information (“average mass error [ppm]”), correlation of fragment ion intensities between the detected light and heavy peptides (“dot product L/H”) and correlation of fragment ion intensities between the detected peptides measured by PRM and the experimental library spectrum from Skyline (“library dot product” separately for light and heavy) were exported from Skyline. Peptide identifications with a dot product L/H > 0.9 and a library dot product > 0.85 were included for the overall ratio (L/H) calculation. The ratio of the respective MS2 peak areas (“total area fragment” L/H) was used for the ratio (L/H) calculation.
Created on 11/11/20, 6:25 AM
Clustergrammer Heatmap
 
Download
7memberCommunity_PlateB.sky.zip2025-07-02 21:47:56501212247
7memberCommunity_PlateA.sky.zip2025-07-02 21:47:56501212247
7memberCommunity_PlateD.sky.zip2025-07-02 21:47:56501212247
7memberCommunity_PlateC.sky.zip2025-07-02 21:47:56501212247
7memberCommunity_PlateB.sky.zip2025-07-02 21:47:56501212247
210723-ATI-barley-Pt14_2025-02-24_01-08-00.sky.zip2025-07-02 20:45:211010198733
210423-ATI-barley-Pt13_2025-02-24_01-07-11.sky.zip2025-07-02 20:45:201010194027
210416-ATI-barley-Pt12_2025-02-24_01-06-33.sky.zip2025-07-02 20:45:181010193843
210415-ATI-barley-Pt11_2025-02-24_01-05-41.sky.zip2025-07-02 20:45:161010194029
210302-ATI-barley-Pt10_2025-02-24_01-05-05.sky.zip2025-07-02 20:45:151010194234
210224-ATI-barley-Pt9_2025-02-24_01-04-22.sky.zip2025-07-02 20:45:131010194031
210217-ATI-barley-Pt8_2025-02-24_01-03-46.sky.zip2025-07-02 20:45:121010194029
210210-ATI-barley-Pt7_2025-02-24_01-03-02.sky.zip2025-07-02 20:45:101010194631
210203-ATI-barley-Pt6_2025-02-24_01-02-20.sky.zip2025-07-02 20:45:091010195031
210129-ATI-barley-Pt5_2025-02-24_01-01-22.sky.zip2025-07-02 20:45:071010195831
200731-ATI-barley-Pt4_2025-02-24_01-00-26.sky.zip2025-07-02 20:45:061010198719
200717-ATI-barley-Pt3_2025-02-24_00-58-01.sky.zip2025-07-02 20:45:041010198755
200709-ATI-barley-Pt2-Response_2025-02-24_00-56-48.sky.zip2025-07-02 20:45:01101019957
200709-ATI-barley-Pt2_2025-02-24_00-55-11.sky.zip2025-07-02 20:45:011010199136
200602-ATI-barley-Pt1_2025-02-24_00-25-35.sky.zip2025-07-02 20:44:591010199331
TPAD_CSF1A_Batch1-multiNF-DIANN.sky.zip2025-07-01 17:49:472,85327,12832,575259,53243
TPAD_CSF1A_Batch1-multiNF-DIANN-grouped.sky.zip2025-07-01 17:41:312,67226,43931,769253,11943
TPAD_CSF1B_Batch2-multiNF-DIANN.sky.zip2025-07-01 15:26:132,85327,12832,575259,53241
TPAD_CSF1B_Batch2-multiNF-DIANN-grouped.sky.zip2025-07-01 15:17:422,67226,43931,769253,11941
TPAD_CSF2A_Batch3-multiNF-DIANN.sky.zip2025-07-01 14:13:302,85327,12832,575259,53243
TPAD_CSF2A_Batch3-multiNF-DIANN-grouped.sky.zip2025-07-01 14:04:582,67226,43931,769253,11943
TPAD_CSF2B_Batch4-multiNF-DIANN.sky.zip2025-07-01 11:21:372,85327,12832,575259,53243
TPAD_CSF2B_Batch4-multiNF-DIANN-grouped.sky.zip2025-07-01 11:09:482,67226,43931,769253,11943
TPAD_CSF3A_Batch5-multiNF-DIANN.sky.zip2025-06-30 15:31:332,85327,12832,575259,53243
TPAD_CSF3A_Batch5-multiNF-DIANN-grouped.sky.zip2025-06-30 15:23:252,67226,43931,769253,11943
TPAD_CSF3B_Batch6-multiNF-DIANN.sky.zip2025-06-30 14:43:542,85327,12832,575259,53241
TPAD_CSF3B_Batch6-multiNF-DIANN-grouped.sky.zip2025-06-30 14:36:142,67226,43931,769253,11941
TPAD_CSF4_Batch7-multiNF-DIANN.sky.zip2025-06-30 13:55:172,85327,12832,575259,53242
TPAD_CSF4_Batch7-multiNF-DIANN-grouped.sky.zip2025-06-30 13:46:482,67226,43931,769253,11942
TPAD_CSF5_Batch8-multiNF-DIANN.sky.zip2025-06-30 13:02:062,85327,12832,575259,53254
TPAD_CSF5_Batch8-multiNF-DIANN-grouped.sky.zip2025-06-30 11:52:172,67226,43931,769253,11954
METRIC_Eclipse_PSB_All_QCs_2025-06-27_01-27-04.sky.zip2025-06-26 22:27:151666233
Exp_CSF_GPF_A_2024-05-06_21-16-47.sky.zip2025-06-25 18:12:201,8297,3787,37855,0401
2024-05 CSF LIT GPF-MSFragger-3.sky.zip2025-06-25 18:12:201,0825,0956,01940,4016
240207_gpf_2024-06-04_10-24-18.sky.zip2025-06-25 18:12:201,2886,98410,593126,0861
230305_ev2_prm_final_inj1_2024-06-04_07-32-10.sky.zip2025-06-25 18:12:207222,0892,08914,44942
230124_p2_neo_30min_3500targets_opt_trans_pepleveldilution_2024-06-04_06-58-16.sky.zip2025-06-25 18:12:201,0273,5013,50111,42041
CSF_neurod105_assay_individuals_manual_2024-06-03_15-26-36.sky.zip2025-06-25 18:12:201029029026,34537
Exp_CSF_MMCC_quant_all_adjBound_opttrans_nochick_2024-06-03_14-53-02.sky.zip2025-06-25 18:12:201,2058,3748,37424,93427
OT_GPF_PRM_survey_MMCC_boundaries_opttrans_nochick_2024-06-03_14-36-08.sky.zip2025-06-25 18:12:201,2801,9711,9715,80127
LIT_GPF_survey_newAlign_MMCC_boundaries_opttrans_nochick_2024-06-02_15-26-11.sky.zip2025-06-25 18:12:207982,0352,0355,99827
Aducanumab_Selectivity_2025-06-19_12-58-48.sky.zip2025-06-19 09:59:0644851236
hela_isolation_window_concentration_2000ng.sky.zip2025-06-02 18:36:1910,365188,947223,7653,101,14818
hela_isolation_window_experiment_200ng.sky.zip2025-06-02 18:36:1910,365188,947223,7653,101,14818
hela_isolation_window_experiment_500ng.sky.zip2025-06-02 18:36:1910,364188,947223,7653,101,14818
hela_isolation_window_experiment_1000ng.sky.zip2025-06-02 18:36:1910,365188,947223,7653,101,14818
2025-0405-MMCC-EV-Astral-noimpute_2025-05-29_11-52-05.sky.zip2025-06-02 18:36:194,90737,54742,331335,89142
2025-0405-MMCC-EV-Actis-noimpute_2025-05-29_11-46-45.sky.zip2025-06-02 18:36:195,18541,97847,810380,07242
SMTG-low-value-imputed_2025-05-01_14-22-15.sky.zip2025-06-01 21:38:1710,383187,220217,1092,214,24878
SMTG-MissForest-imputed_2025-05-01_11-41-41.sky.zip2025-06-01 20:04:5710,383187,220217,1092,214,24878
SMTG-nettle-imputed_2025-04-30_12-25-18.sky.zip2025-06-01 18:16:1410,639215,139251,4792,483,95978
SMTG-unimputed_2025-04-30_08-55-40.sky.zip2025-06-01 13:32:5610,639215,139251,4792,483,95978
TEI-REX-unimputed_2025-04-29_15-46-15.sky.zip2025-06-01 11:49:381,30749,85259,007585,98796
TEI-REX-nettle-imputed_2025-04-29_13-36-50.sky.zip2025-06-01 11:15:251,30749,85259,007585,98796
MagNet-holdout-nettle-imputed_2025-05-01_08-50-25.sky.zip2025-06-01 09:40:175,29914,11015,07460,28842
hela_isolation_window_concentration_2000ng.sky.zip2025-05-30 15:25:4610,365188,947223,7653,101,14818
ecoli_large_replicates_loaded_refined_2024-05-30_14-02-04.sky.zip2025-05-30 12:00:183669899894,9408
ecoli_large_replicates_loaded_2024-05-30_14-00-59.sky.zip2025-05-30 12:00:184611,3021,3027,5248
ecoli_large_replicates_2024-05-30_14-00-05.sky.zip2025-05-30 12:00:184611,3021,3027,5240
ecoli_subset_replicates_refined_cv_2024-05-30_13-58-18.sky.zip2025-05-30 12:00:187592,2662,26612,8072
ecoli_subset_replicates_refined_2024-05-30_13-57-25.sky.zip2025-05-30 12:00:187592,4372,43713,6022
ecoli_subset_replicates_2024-05-30_13-56-16.sky.zip2025-05-30 12:00:187592,4372,44130,8572
gpf_results_importer_2024-05-30_13-54-14.sky.zip2025-05-30 12:00:181,1925,3967,42785,6731
gpf_results_manual_2024-05-30_13-52-23.sky.zip2025-05-30 12:00:181,1925,3967,42785,6731
pq500_100spd_plasma_final_lightheavy_replicates_2024-05-30_13-50-10.sky.zip2025-05-30 11:58:415798181,62213,69910
pq500_60spd_plasma_final_lightheavy_replicates_2024-05-30_13-48-26.sky.zip2025-05-30 11:58:415798181,62213,87610
pq500_100spd_plasma_final_replicates_2024-05-30_13-47-38.sky.zip2025-05-30 11:58:415798188187,08110
pq500_60spd_plasma_final_replicates_2024-05-30_13-46-43.sky.zip2025-05-30 11:58:415798188186,97710
pq500_100spd_plasma_multireplicate_results_refined_2024-05-30_13-46-07.sky.zip2025-05-30 11:58:415798188187,0811
pq500_60spd_plasma_multireplicate_results_refined_2024-05-30_13-45-40.sky.zip2025-05-30 11:58:415798188186,9771
pq500_100spd_plasma_multireplicate_results_2024-05-30_13-45-07.sky.zip2025-05-30 11:58:415798188187,6512
pq500_60spd_plasma_multireplicate_results_2024-05-30_13-44-21.sky.zip2025-05-30 11:58:415798188187,6012
pq500_100spd_neat_multireplicate_results_refined_2024-05-30_13-43-42.sky.zip2025-05-30 11:58:415798188187,6891
pq500_60spd_neat_multireplicate_results_refined_2024-05-30_13-43-05.sky.zip2025-05-30 11:58:415798188187,6011
pq500_100spd_neat_multireplicate_results_2024-05-30_13-42-26.sky.zip2025-05-30 11:58:4157981881811,0881
pq500_60spd_neat_multireplicate_results_2024-05-30_13-41-26.sky.zip2025-05-30 11:58:4157981881811,0881
pq500_60spd_neat_multireplicate_2024-05-30_13-40-53.sky.zip2025-05-30 11:58:4157981881811,0880
hela_isolation_window_experiment_200ng.sky.zip2025-05-30 01:29:3910,365188,947223,7653,101,14818
hela_isolation_window_experiment_500ng.sky.zip2025-05-30 00:53:5310,364188,947223,7653,101,14818
hela_isolation_window_experiment_1000ng.sky.zip2025-05-29 23:15:1110,365188,947223,7653,101,14818
2025-0405-MMCC-EV-Astral-noimpute_2025-05-29_11-52-05.sky.zip2025-05-29 12:13:324,90737,54742,331335,89142
2025-0405-MMCC-EV-Actis-noimpute_2025-05-29_11-46-45.sky.zip2025-05-29 12:03:295,18541,97847,810380,07242
20240709_OBIPhA.sky.zip2025-05-16 09:25:513333723512
Swaney-IPMS-Data-DIANN_2025-05-15_11-53-43.sky.zip2025-05-15 12:02:265,18545,78152,836422,66115
Vial Comparison Post 01152025 v1 (not daily)_2025-04-29_15-52-29.sky.zip2025-04-30 21:22:2310242419
Vial Comparison Pre v2_2025-04-29_15-49-25.sky.zip2025-04-30 21:22:2310242423
ATI_Samples_2023_2025-04-26_13-39-03.sky.zip2025-04-28 10:30:1413244828042
ATI_Response_2023_2025-04-26_13-25-06.sky.zip2025-04-28 10:30:1413244828018
ATI_Samples_2022_2025-02-20_23-31-07.sky.zip2025-04-28 10:30:1012234626848
ATI_Samples_2021_2025-02-20_23-21-52.sky.zip2025-04-28 10:30:0812234626830
2023_ATIsamples_circe_2025-02-20_13-24-11.sky.zip2025-04-25 14:58:1713224325096
2022_ATIsamples_circe_2025-02-20_13-17-06.sky.zip2025-04-25 14:58:0912224325097
2021_ATIsamples_circe_2025-02-20_13-06-53.sky.zip2025-04-25 14:58:0212224325094
deamidation_localization_gS_7-18_2025-04-24_20-52-46.sky.zip2025-04-25 12:05:18144181
synthetic_heavy_gS_peptides_4-21-25_2025-04-21_16-42-22.sky.zip2025-04-25 12:05:1516116632

Experimental spectral libraries were built within Skyline using DDA and PRM isoDTB data processed with MaxQuant that have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022426.